Point of Care Solutions 2017-09-07T04:08:18+00:00

Point-of-Care Solutions for Cell-Based Therapies (PXP)


PXP™ allows for the rapid, automated processing of autologous peripheral or bone marrow derived stem cells at the point-of-care, such as surgical centers or clinics.

  • Ensures consistently high recoveries of mononuclear cells (MNC) in a targeted volume
  • Simultaneously processes multiple bone marrow units
  • Automates the volume reduction process
  • Processes bone marrow without cell separation media or sedimentation agent

The PXP™ System includes:

  • PXP™ device
  • Docking station
  • Processing set
  • XpressTRAK™ software
  • Accessories
  • Consistently high MNC recoveries and CD34+ recoveries1
  • Precise delivery of target final volume1
  • Reliable collection of all fractions: buffy coat, RBCs and plasma
  • Automated, closed, sterile system
  • Integrated sampling pillows for pre- and post-processing sterile sample collection
  • Low residual red blood cell contamination
  • Unit is self-powered by a rechargeable NiMH battery
  • Simultaneous processing of up to six samples streamlines the workflow
  • Rapid sample separation and concentration complete in 30 minutes
  • Separate collection bags for buffy coat, plasma, and RBCs
  • Reliable and reproducible reduction of initial unit volume to a user-determined final volume
  • XpressTRAK software provides quick and accurate data tracking and documentation specific to each bone marrow unit processed
  • Captures sample processing data for quality assurance and compliance with current good tissue practices (cGTP) and good manufacturing practices (cGMP)
  • Stores processing data in a searchable, sortable database
  • XpressLINK software provides the ability to link data from PXP™ devices in real time

XpressTRAK Data Acquisition Software collects processing and system information through a user interface and stores it in a searchable, sortable database.

1Data on file.
Note: The safety and effectiveness of this device for in vivo indications for use has not been established.